B.D. Rush

820 total citations
23 papers, 698 citations indexed

About

B.D. Rush is a scholar working on Surgery, Pharmacology and Oncology. According to data from OpenAlex, B.D. Rush has authored 23 papers receiving a total of 698 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 6 papers in Pharmacology and 5 papers in Oncology. Recurrent topics in B.D. Rush's work include Gastrointestinal motility and disorders (4 papers), Drug Transport and Resistance Mechanisms (4 papers) and Inflammatory mediators and NSAID effects (4 papers). B.D. Rush is often cited by papers focused on Gastrointestinal motility and disorders (4 papers), Drug Transport and Resistance Mechanisms (4 papers) and Inflammatory mediators and NSAID effects (4 papers). B.D. Rush collaborates with scholars based in United States, Australia and South Korea. B.D. Rush's co-authors include Mary J. Ruwart, M.S. Klepper, Ming‐Shang Kuo, W. Morozowich, Tiehua Huang, Ping Gao, Michael J. Hageman, William P. Pfund, N.M. Friedle and Gerald J. Kolaja and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and Journal of Medicinal Chemistry.

In The Last Decade

B.D. Rush

23 papers receiving 647 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
B.D. Rush United States	12	242	145	115	113	100	23	698
Chyung S. Cook United States	13	268 1.1×	200 1.4×	171 1.5×	104 0.9×	64 0.6×	29	850
Conny Bogentoft Sweden	14	87 0.4×	165 1.1×	40 0.3×	38 0.3×	59 0.6×	61	617
Anthony R. DiSanto United States	15	86 0.4×	73 0.5×	110 1.0×	49 0.4×	46 0.5×	32	596
Yasutaka Igari Japan	14	146 0.6×	152 1.0×	177 1.5×	143 1.3×	44 0.4×	19	603
Rebecca L. Oberle United States	7	196 0.8×	68 0.5×	86 0.7×	137 1.2×	44 0.4×	9	472
Tai Matsuzawa Japan	10	260 1.1×	223 1.5×	165 1.4×	126 1.1×	55 0.6×	19	809
SHIKIFUMI KITAZAWA Japan	14	107 0.4×	163 1.1×	55 0.5×	170 1.5×	31 0.3×	61	579
Karen Kleberg Denmark	12	611 2.5×	148 1.0×	41 0.4×	214 1.9×	86 0.9×	15	961
Åsa Sjöberg Sweden	6	234 1.0×	111 0.8×	92 0.8×	311 2.8×	50 0.5×	6	572
A.P. Intoccia United States	8	59 0.2×	96 0.7×	42 0.4×	81 0.7×	38 0.4×	14	438

Countries citing papers authored by B.D. Rush

Since Specialization

Citations

This map shows the geographic impact of B.D. Rush's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B.D. Rush with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B.D. Rush more than expected).

Fields of papers citing papers by B.D. Rush

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B.D. Rush. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B.D. Rush. The network helps show where B.D. Rush may publish in the future.

Co-authorship network of co-authors of B.D. Rush

This figure shows the co-authorship network connecting the top 25 collaborators of B.D. Rush. A scholar is included among the top collaborators of B.D. Rush based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B.D. Rush. B.D. Rush is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gao, Ping, B.D. Rush, William P. Pfund, et al.. (2003). Development of a supersaturable SEDDS (S‐SEDDS) formulation of paclitaxel with improved oral bioavailability. Journal of Pharmaceutical Sciences. 92(12). 2386–2398. 282 indexed citations

Islam, Imadul, K. T. Chong, T. J. MCQUADE, et al.. (1994). Evaluation of a vitamin-cloaking strategy for oligopeptide therapeutics: biotinylated HIV-1 protease inhibitors. Journal of Medicinal Chemistry. 37(2). 293–304. 10 indexed citations

Rush, B.D., et al.. (1991). Absolute oral bioavailability of ditekiren, a renin inhibitor peptide, in conscius rats. International Journal of Pharmaceutics. 73(3). 231–237. 13 indexed citations

Peters, Kenneth M., et al.. (1989). 16, 16 Dimethyl prostaglandin E2 decreases the formation of collagen in fibrotic rat liver slices. Prostaglandins. 37(4). 445–456. 8 indexed citations

Rush, B.D., et al.. (1989). Hepatic protection by 16,16-dimethyl prostaglandin E2 (DMPG) against acute aflatoxin B1-induced injury in the rat. Prostaglandins. 37(6). 683–693. 29 indexed citations

Ruwart, Mary J., et al.. (1985). 16,16-Dimethyl PGE2 and fatty acids protect hepatocytes against CCl4-induced damage. In Vitro Cellular & Developmental Biology - Plant. 21(8). 450–452. 12 indexed citations

Gilbertson, Terry J., R.P. Stryd, M.N. Brunden, Christina A. Christianson, & B.D. Rush. (1984). Changes in thymidine uptake in the gastrointestinal tract of the rat following treatment with 16,16-dimethyl prostaglandin E2. Prostaglandins. 27(6). 887–898. 5 indexed citations

Rush, B.D. & Mary J. Ruwart. (1984). Prazosin inhibits small intestinal transit in the rat. British Journal of Pharmacology. 82(3). 547–548. 3 indexed citations

Gilbertson, Terry J., Mary J. Ruwart, R.P. Stryd, et al.. (1983). Partial characterization of the gastrointestinal weight changes produced in the female rat by 16,16-dimethylprostaglandin E2. Prostaglandins. 26(5). 745–759. 21 indexed citations

10.

Ruwart, Mary J., B.D. Rush, N.M. Friedle, R. C. Piper, & Gerald J. Kolaja. (1981). Protective effects of 16,16-dimethyl PGE2 on the liver and kidney. Prostaglandins. 21. 97–102. 73 indexed citations

11.

Rush, B.D., Mary J. Ruwart, & Charles Day. (1981). The mechanism of action of the hypocholesterolemic drug p-(1-adamantyloxy)-aniline. Atherosclerosis. 39(3). 345–351. 2 indexed citations

12.

Ruwart, Mary J., M.S. Klepper, & B.D. Rush. (1980). Prostaglandin stimulation of gastrointestinal transit in post-operative ileus rats. Prostaglandins. 19(3). 415–426. 7 indexed citations

13.

Ruwart, Mary J., M.S. Klepper, & B.D. Rush. (1980). Clonidine delays small intestinal transit in the rat.. Journal of Pharmacology and Experimental Therapeutics. 212(3). 487–490. 93 indexed citations

14.

Ruwart, Mary J., M.S. Klepper, & B.D. Rush. (1979). Carbachol stimulation of gastrointestinal transit in the postoperative lleus rat. Journal of Surgical Research. 26(1). 18–26. 44 indexed citations

15.

Ruwart, Mary J., M.S. Klepper, & B.D. Rush. (1979). Ionic composition of small intestinal secretion induced by PGE2. Prostaglandins and Medicine. 2(4). 285–291. 1 indexed citations

16.

Ruwart, Mary J., M.S. Klepper, & B.D. Rush. (1979). Evidence for noncholinergic mediation of small intestinal transit in the rat.. Journal of Pharmacology and Experimental Therapeutics. 209(3). 462–465. 30 indexed citations

17.

Ruwart, Mary J., M.S. Klepper, & B.D. Rush. (1978). The beneficial effects of prostaglandins in post-operative ileus. Gastroenterology. 74(5). 1088–1088. 2 indexed citations

18.

Hersh, L.B., Louis A. Barker, & B.D. Rush. (1978). Effect of sodium chloride on changing the rate-limiting step in the human placental choline acetyltransferase reaction.. Journal of Biological Chemistry. 253(14). 4966–4970. 25 indexed citations

19.

Rush, B.D., et al.. (1977). The protein-sparing effect of peripherally administered amino acids.. PubMed. 43(9). 562–4. 2 indexed citations

20.

Buchanan, J. G., B.D. Rush, & G. C. de Gruchy. (1966). METHYLDOPA AND ACQUIRED HÆMOLYTIC ANÆMIA. The Medical Journal of Australia. 2(15). 700–701. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact